Get In Touch
Daratumumab
JOHNSON & JOHNSON PVT LTD
Treatment of multiple myeloma
1 VIAL(s) OF 20ML
Injection
Darzalex 400mg Injection is an anti-cancer medicine used mainly in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. It contains daratumumab, a targeted therapy that works by attaching to specific proteins on cancer cells and helping the immune system destroy them. Given under medical supervision, Darzalex plays an important role in slowing disease progression and improving treatment outcomes when used alone or in combination with other cancer medicines.
Like all cancer medicines, Darzalex 400mg Injection may cause some side effects. These vary from person to person and are usually manageable under medical supervision.
It is important to inform your doctor immediately if you experience severe symptoms such as persistent fever, difficulty breathing, chest tightness, or unusual bleeding. Regular blood tests are usually required during treatment to monitor your health and manage any side effects early.
Should be administered only under strict medical supervision in a hospital setting.May cause infusion reactions such as fever, chills, cough, or breathing difficulty, especially during the first dose.
Can lower blood cell counts, increasing the risk of infections and bleeding regular blood monitoring is required.
Inform your doctor before any blood transfusion, as it may interfere with blood compatibility tests.
Not recommended during pregnancy or breastfeeding.
Store in a refrigerator at 2°C to 8°C.
Do not freeze or shake the vial.
Darzalex 400mg Injection is used to treat multiple myeloma, a type of blood cancer that affects plasma cells. It may be given alone or in combination with other anti-cancer medicines.
It contains daratumumab, a monoclonal antibody that targets a specific protein (CD38) on myeloma cells. This helps the immune system identify and destroy cancer cells.
Darzalex is given as an intravenous (IV) infusion by a healthcare professional in a hospital or clinical setting. The dose and schedule are decided by your doctor.
Common side effects include infusion reactions (fever, chills), fatigue, nausea, and low blood cell counts, which may increase the risk of infections.
No, Darzalex is not recommended during pregnancy or breastfeeding. Patients should use effective contraception during treatment and as advised by their doctor.
Darzalex 400mg Injection is an anti-cancer medicine used mainly in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. It contains daratumumab, a targeted therapy that works by attaching to specific proteins on cancer cells and helping the immune system destroy them. Given under medical supervision, Darzalex plays an important role in slowing disease progression and improving treatment outcomes when used alone or in combination with other cancer medicines.
Although rare, these require immediate medical attention:
These are usually mild and may improve as your body adjusts to the medicine:
It is important to inform your doctor immediately if you experience severe symptoms such as persistent fever, difficulty breathing, chest tightness, or unusual bleeding. Regular blood tests are usually required during treatment to monitor your health and manage any side effects early.
Should be administered only under strict medical supervision in a hospital setting. May cause infusion reactions such as fever, chills, cough, or breathing difficulty, especially during the first dose.
Can lower blood cell counts, increasing the risk of infections and bleeding regular blood monitoring is required
Inform your doctor before any blood transfusion, as it may interfere with blood compatibility tests.
Not recommended during pregnancy or breastfeeding.
Store in a refrigerator at 2°C to 8°C.
Do not freeze or shake the vial.
Darzalex 400mg Injection is used to treat multiple myeloma, a type of blood cancer that affects plasma cells. It may be given alone or in combination with other anti-cancer medicines.
It contains daratumumab, a monoclonal antibody that targets a specific protein (CD38) on myeloma cells. This helps the immune system identify and destroy cancer cells.
Darzalex is given as an intravenous (IV) infusion by a healthcare professional in a hospital or clinical setting. The dose and schedule are decided by your doctor.
Common side effects include infusion reactions (fever, chills), fatigue, nausea, and low blood cell counts, which may increase the risk of infections.
No, Darzalex is not recommended during pregnancy or breastfeeding. Patients should use effective contraception during treatment and as advised by their doctor.
Sourced from Manufacturers
Air Express Delivery
Trusted Medicines
Get Up to 85% Off
